期刊文献+

补阳还五汤保护急性脊髓损伤的网络药理学分析 被引量:1

Network Pharmacological Analysis of Buyang Huanwu Decoction in Protecting Acute Spinal Cord Injury
下载PDF
导出
摘要 目的分析补阳还五汤的有效活性成分及其保护急性脊髓损伤(ASCI)的作用机制。方法通过中药系统药理学数据库与分析平台(TCMSP)、中草药数据库(TCMID)、中国中医药学主题词表(TCMeSH)获取补阳还五汤的有效活性成分及化合物靶点,利用人类基因数据库(GeneCards)、带有证据语句的疾病基因搜索引擎(DigSee)网站、在线人类孟德尔遗传数据库(OMIM)提取的ASCI靶点,绘制Venny图以获得交集靶点,采用Cytoscape 3.7.2获得化合物-靶点-疾病网络。凭借STRING网站获取蛋白互作网络图(PPI),利用R语言V4.1.1进行基因本体(GO)功能富集分析、京都基因与基因组百科全书(KEGG)生物通路富集分析,最后运用分子对接技术及药理实验进行验证。结果经初步筛选,槲皮素、木犀草素、山奈酚、异鼠李素等多种关键中药成分可能是通过调控核受体共激活剂2(NCOA2)、热休克蛋白90ɑ(HSP90AA1)、前列腺素内过氧化物合成酶2(PTGS2)、前列腺素内过氧化物合成酶1(PTGS1)、Jun原癌基因(JUN)、蛋白激酶Bɑ(AKT1)、白介素6(IL-6)等核心靶点发挥对ASCI的保护作用。京都基因和基因组百科全书(KEEG)富集分析主要涉及到糖尿病并发症晚期糖基化终末产物(AGEs)-糖基化终末产物受体(RAGE)信号通路、白细胞介素-17(IL-17)信号通路、肿瘤坏死因子(TNF)信号通路等,同时动物实验证实哺乳动物雷帕霉素靶蛋白(mTOR)信号通路也是补阳还五汤保护ASCI的核心通路。结论补阳还五汤可能通过多靶点、多功能、多通路保护ASCI,PTGS1、PTGS2、AKT、Beclin 1、mTOR可能为其中的核心靶点,mTOR通路为其发挥保护作用的核心通路。 Objective To analyze the active components of Buyang Huanwu Decoction and its mechanism of action in protecting acute spinal cord injury.Methods Tradition Chinese Medicine Systems Pharmacology Database and Analysis Plaform,Traditional Chinese Medicine Integrated Database and Traditional Chinese Medicine Integrated Database were used to extract the compound composition and compound target relationship of Buyang Huanwu Decoction.Gene Cards,OMIM and DigSee websites were used to extract the disease targets of acute Spinal cord injury.Vennny map is drawn through online Venn website to obtain intersection targetsand relevant information was imported into CytoscapeCytoscape3.7.2 to obtain the compound-target-disease network.According to the intersection targets,the STRING website obtained the protein interaction network,the R language V4.1.1 carried on the GO and KEGG enrichment analysis.Finally,molecular docking technology and pharmacological experiments were used to verify.Results After preliminary screening,many key traditional Chinese medicine ingredients such as quercetin,luteolin,kaempferol,and isorhamnetin may be involved in regulating nuclear receptor coactivator 2(NCOA2)and heat shock protein 90ɑ(HSP90AA1),prostaglandin endoperoxide synthetase 2(PTGS2),prostaglandin endoperoxide synthetase 1(PTGS1),Jun proto-oncogene(JUN),protein kinase BɑCore targets such as(AKT1)and interleukin-6(IL-6)play a protective role on ASCI.KEGG enrichment analysis involved AGE-RAGE signaling pathway,interleukin-17 signaling pathway,tumor necrosis factor signaling pathway and other complications of diabetes.Meanwhile,animal experiments have also confirmed that the mammalian rapamycin target protein(mTOR)signaling pathway is also the core pathway of Buyang Huanwu Tang in protecting ASCI.Conclusion Buyang Huanwu Tang may protect ASCI through multiple targets,multiple functions,and multiple pathways.PTGS1,PTGS2,AKT,Beclin 1,and mTOR may be the core targets,while mTOR pathway may be the core pathway that plays a protective role.
作者 卜献忠 卜保献 张冠鹏 卜若晨 唐福波 秦百君 麦威 钟远鸣 BU Xianzhong;BU Baoxian;ZHANG Guanpeng;BU Ruochen;TANG Fubo;QIN Baijun;MAI Wei;ZHONG Yuanming(First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,China;Guangxi University of Chinese Medicine,Nanning 530001,China;Luoyang Zhenggu Hospital of Henan Province/Orthopedic Hospital of Henan Province,Luoyang 471002,China;Hainan Medical University,Haikou 570102,China;First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530023,China;Guangxi Medical University Cancer Hospital,Nanning 530021,China)
出处 《世界科学技术-中医药现代化》 CSCD 北大核心 2024年第2期375-389,共15页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 河南省中医药科学研究专项课题普通课题(20-21ZY2083):补阳还五汤对脊髓损伤后mTOR信号通路及其介导的细胞自噬影响的实验研究,负责人:卜保献 河南省中医药科学研究专项课题(2023ZXZX1003):整合蛋白质组学和代谢组学探讨加味补阳还五汤干预脊髓型颈椎病的临床疗效及血清生物标记物研究,负责人:卜献忠 洛阳市2022-2024年度中医重点学科(中西医结合医学-脊柱外科),负责人:卜保献。
关键词 补阳还五汤 急速脊髓损伤 自噬 雷帕霉素 网络药理学 分子对接 实验验证 作用机制 Buyang Huanwu Decoction Acute Spinal cord injury Autophagy Rapamycin Network pharmacology Molecular docking Experimental verification Mechanism of action
  • 相关文献

参考文献32

二级参考文献397

共引文献1183

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部